It had been a while since I participated in a Twitterview – a real-time interview via Twitter – so I was glad to have the opportunity to join TABB Group’s senior analyst Kevin McPartland in yesterday’s “DerivChat” conversation. SunGard’s own director of analyst relations, Alyssa Gilmore, moderated the discussion, which focused on OTC derivatives.
If you didn’t see it happening in real time, you can read the interview here or in Twitter Search under #derivchat. And if you have your own answer to one of the questions or want to ask something new, leave a comment for us below.
↧